Home » Authors » Trista Morrison

Articles by Trista Morrison

NewCo News: Sanaria Nears Clinic with Live Attenuated Malaria Vaccine

Jan. 29, 2008

By Trista Morrison

Amgen Earnings Beat Estimates, But ESA Uncertainty Looms

Jan. 28, 2008

By Trista Morrison

Despite regulatory and reimbursement challenges to its erythropoietin stimulating agent (ESA) franchise, Amgen Inc. beat analyst estimates for earnings in the fourth quarter of 2007. (BioWorld Today)

Amgen Earnings Beat Estimates, But ESA Uncertainty Looms

Jan. 28, 2008

By Trista Morrison

Despite regulatory and reimbursement challenges to its erythropoietin stimulating agent (ESA) franchise, Amgen Inc. beat analyst estimates for earnings in the fourth quarter of 2007. (BioWorld Today)

Orexigen Prices $77M Follow-On as Obesity Trials Move Ahead

Jan. 25, 2008

By Trista Morrison

Orexigen Prices $77M Follow-On as Obesity Trials Move Ahead

Jan. 25, 2008

By Trista Morrison

Adverse Events in Albuferon Trials Devastate HGS Shares

Jan. 24, 2008

By Trista Morrison

Adverse Events in Albuferon Trials Devastate HGS Shares

Jan. 24, 2008

By Trista Morrison

KV Pharma Buys Gestiva from Hologic for $82M Cash

Jan. 23, 2008

By Trista Morrison

KV Pharma Buys Gestiva from Hologic for $82M Cash

Jan. 23, 2008

By Trista Morrison

The Myths and Realities of Corporate Venture Capital

Jan. 22, 2008

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...